Médico, residente de Ginecología y Obstetricia, Universidad de La Sabana, Bogotá.
Médico, residente de Ginecología y Obstetricia Universidad de La Sabana, Bogotá (Colombia).
Rev Colomb Obstet Ginecol. 2020 Dec;71(4):365-373. doi: 10.18597/rcog.3543.
To report a case of pure red-cell aplasia secondary to pregnancy and to conduct a review of the literature regarding diagnosis and treatment, as well as maternal and perinatal prognosis.
This is the case of a 24-year-old patient at 34 weeks of gestation, referred to a regional public referral hospital due to anemia. Bone marrow biopsy was performed, leading to the diagnosis of pregnancy-related pure red-cell aplasia. The patient received serial red blood cell transfusions. Delivery by Cesarean section at term resulted in a healthy newborn. Hemoglobin values remained stable during the postoperative period. A literature search was conducted in Medline via PubMed, LILACS, SciELO and ScienceDirect using the terms "pregnancy" and "pure red-cell aplasia". Case reports, case series and literature reviews in English and Spanish published between January 1999 and January 2020 that report pregnant women with pure red-cell aplasia were included. Information on diagnosis, treatment and maternal and perinatal prognosis was collected. Three of the authors selected the studies by title and abstract; A descriptive synthesis is provided.
Overall, 828 titles were identified; of these,818 were discarded after reviewing the inclusions criteria. Ten articles were included: six case reports, three case reports with literature review, and one case report in the poster modality, for a total number of 10 reported cases. Diagnosis was based on low hemoglobin levels and compromised erythroid cell line in bone marrow biopsy. Treatment consists of red blood cell transfusions, with good maternal and fetal prognosis.
Diagnosis of pure red-cell aplasia during pregnancy requires bone marrow biopsy. With transfusion support, maternal perinatal prognosis is good. Further studies are required to assess the safety and efficacy of steroid use in this pregnancy-related condition.
报告一例妊娠相关纯红细胞再生障碍性贫血病例,并对其诊断、治疗以及母婴围生期预后进行文献复习。
这是一例 24 岁妊娠 34 周患者,因贫血转诊至区域公立转诊医院。进行骨髓活检,诊断为妊娠相关性纯红细胞再生障碍性贫血。患者接受了多次红细胞输血。足月行剖宫产分娩,新生儿健康。术后期间血红蛋白值保持稳定。在 Medline 中通过 PubMed、LILACS、SciELO 和 ScienceDirect 以“pregnancy”和“pure red-cell aplasia”为关键词进行文献检索,纳入 1999 年 1 月至 2020 年 1 月期间发表的英文和西班牙文的病例报告、病例系列和文献综述,报告妊娠合并纯红细胞再生障碍性贫血的患者。收集了诊断、治疗以及母婴围生期预后的信息。三位作者通过标题和摘要选择了研究;提供了描述性综合分析。
共确定了 828 个标题;其中,818 个在审查纳入标准后被排除。纳入了 10 篇文章:6 篇病例报告,3 篇病例报告和文献综述,以及 1 篇海报形式的病例报告,共报道了 10 例病例。诊断基于低血红蛋白水平和骨髓活检中红细胞系受损。治疗包括红细胞输血,母婴围生期预后良好。
妊娠期间诊断纯红细胞再生障碍性贫血需要进行骨髓活检。通过输血支持,母婴围生期预后良好。需要进一步研究评估在这种妊娠相关性疾病中使用类固醇的安全性和有效性。